XW-015

N/A

Report date: 2025/07/23 15:10:21

Base Information

Drug NameXW-015
Drug Alias NameLong-acting amylin analog XW-015XW-015VRB-102
ClassificationBiologics
Mechanisms of ActionAmylin receptor agonistsCalcitonin receptor agonists
TargetsAmylin ReceptorCalcitonin receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Sciwind Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVerdiva Bio LtdHangzhou Sciwind Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A